Disease modifying therapies modulate retinal layer atrophy in multiple sclerosis: a longitudinal study

被引：0
|
作者：
Al-Louzi, O. [1 ]
Button, J. [1 ]
Lang, A. [2 ]
Bhargava, P. [1 ]
Newsome, S. [1 ]
Carass, A. [2 ]
Balcer, L. [3 ]
Frohman, E. [4 ]
Prince, J. [2 ]
Calabresi, P. [1 ]
Saidha, S. [1 ]
机构：
[1] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA
[3] NYU, Dept Neurol, New York, NY 10016 USA
[4] Univ Texas Southwestern, Dept Neurol, Dallas, TX USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1009
引用
收藏
页码：514 / 515
页数：2
相关论文
共 50 条
  • [21] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
  • [22] The effect of disease modifying therapies on fatigue in multiple sclerosis
    Rivera, Samantha Cruz
    Aiyegbusi, Olalekan Lee
    Meier, Daniela Piani
    Dunne, Achille
    Harlow, Danielle E.
    Henke, Christian
    Kamudoni, Paul
    Calvert, Melanie
    QUALITY OF LIFE RESEARCH, 2024, 33 : S194 - S194
  • [23] Immunosenescence and the risk of disease modifying therapies in Multiple Sclerosis
    Mehling, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 39 - 39
  • [24] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
    Langer-Gould, Annette M.
    Smith, Jessica B.
    Gonzales, Edlin G.
    Piehl, Fredrik
    Li, Bonnie H.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [25] Oral Disease-Modifying Therapies for Multiple Sclerosis
    Kim, Woojun
    Zandona, Manuella Edler
    Kim, Su-Hyun
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 9 - 19
  • [26] The effect of disease modifying therapies on fatigue in multiple sclerosis
    Rivera, Samantha Cruz
    Aiyegbusi, Olalekan Lee
    Meier, Daniela Piani
    Dunne, Achille
    Harlow, Danielle E.
    Henke, Christian
    Kamudoni, Paul
    Calvert, Melanie J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [27] Discontinuing disease-modifying multiple sclerosis therapies
    Krysko, Kristen
    LANCET NEUROLOGY, 2023, 22 (07): : 543 - 545
  • [28] Benign multiple sclerosis in the era of disease modifying therapies
    Diaz-Cruz, C.
    Chua, A. S.
    Healy, B. C.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 425 - 426
  • [29] Aging And Disease Modifying Therapies: Relationship In Multiple Sclerosis
    Zhang, Y.
    Gonzalez-Caldito, N.
    Shirani, A.
    Salter, A.
    Cutter, G.
    Culpepper, W., II
    Wallin, M.
    Wolinsky, J.
    Lublin, F. D.
    Stuve, O.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 135 - 136
  • [30] Current disease-modifying therapies in multiple sclerosis
    Kieseier, BC
    Hartung, HP
    SEMINARS IN NEUROLOGY, 2003, 23 (02) : 133 - 145
12345